Manual lymphatic drainage is the component of lymphoedema treatment that generates the most debate among clinicians and researchers. Unlike compression therapy, which has a clear mechanical rationale and consistent evidence base, the evidence for MLD is more nuanced, effect sizes vary substantially between studies, and the question of which patients benefit most from adding MLD to compression therapy is still being characterised. This makes it worth examining what the research actually shows, rather than accepting either universal endorsement or dismissal.
The Mechanism
The physiological rationale for MLD is well-established. Lymphatic capillaries are anchored to the surrounding connective tissue by filaments. When the skin is stretched by light external pressure, these anchoring filaments pull the capillary walls open, increasing uptake of interstitial fluid. The rhythmic, directional nature of MLD strokes then propels fluid through the initial lymphatics into the collecting vessels and toward functioning lymph nodes. For lymphoedema resulting from node removal or damage, MLD aims to redirect fluid via collateral lymphatic pathways and cutaneous pre-collectors around the obstructed area.
Evidence for Breast Cancer-Related Lymphoedema
The most rigorous evidence concerns breast cancer-related upper limb lymphoedema. A 2011 Cochrane systematic review found that adding MLD to compression therapy produced a modest additional volume reduction compared to compression alone in mild to moderate upper limb lymphoedema. The 2015 MCLONS trial, which randomised 160 women with breast cancer-related lymphoedema to compression plus MLD versus compression alone, found no significant difference in volume reduction at six months. However, the MLD group reported significantly greater improvements in pain, heaviness, and tension, suggesting a symptom benefit that volume measurements do not capture.
Evidence for Lower Limb Lymphoedema
Evidence for lower limb lymphoedema is less extensive. Studies of CDT in lower limb lymphoedema consistently demonstrate substantial volume reductions, but the isolated contribution of MLD versus the multi-layer bandaging and exercise components is difficult to determine because CDT is delivered as an integrated programme. A 2018 review in the Journal of Lymphoedema found that the available evidence supported MLD as a component of intensive treatment in lower limb lymphoedema, particularly for reducing patient-reported heaviness and discomfort, even when objective volume differences were modest.
Simple Lymphatic Drainage
Simple lymphatic drainage is a self-administered version of MLD that patients are taught to perform at home as part of their maintenance programme. The strokes are less precise than those of a trained therapist but replicate the general direction and light-touch principles of professional MLD. Multiple studies have found that patients who perform daily SLD in addition to wearing their compression garment report better symptom control and lower rates of cellulitis than those who rely on garment wear alone. Teaching SLD as a self-management tool is a standard component of lymphoedema education.
When MLD Adds Most Value
The current clinical consensus, reflected in the British Lymphology Society and International Lymphoedema Framework guidelines, is that MLD adds most value in: the intensive phase of CDT as part of reducing initial limb volume; truncal and midline lymphoedema where compression garments cannot be effectively applied; genital and head and neck lymphoedema; lipo-lymphoedema where both adipose and lymphatic components need to be addressed; and in patients who report significant pain, heaviness, or psychological distress for whom the tactile component of MLD provides comfort and engagement with treatment.